| Gene symbol | MAGEC2 | Synonyms | CT10, HCA587, MAGEE1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq27.2 | dbXrefs | |
| Description | MAGE family member C2 | ||||
| GTO ID | GTC0669 |
| Trial ID | 2019-000657-31 |
| Disease | Head and Neck Cancer | Melanoma |
| Altered gene | MAGE-C2 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | MAGE-C2 TCR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Ongoing |
| Title | Adoptive therapy with TCR gene-engineered T cells to treat patients with MAGE-C2-positive melanoma and head and neck cancer |
| Year | 2019 |
| Country | Netherlands |
| Company sponsor | Erasmus MC Cancer Institute |
| Cohort 1 | |||||||
|
|||||||